Pfizer PFE
CEO: Albert Bourla · Pharmaceuticals · 88,000 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $2.2M | $766K | $7.4M | $3.5M | $2.9M | $152K | $17.0M |
| 2024 | $2.2M | $799K | $6.5M | $3.6M | $2.1M | $42K | $15.3M |
| 2023 | $2.1M | $26K | $7.2M | $1.6M | $2.9M | $14K | $14.3M |
| 2022 | $2.1M | — | $6.0M | $3.4M | $1.7M | $187K | $13.5M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Albert Bourla, CEO of Pfizer (PFE), earns $17.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Pfizer has a Pay-for-Performance Score of C (53/100). The company's 3-year total shareholder return is -8.6%, and the say-on-pay shareholder vote passed with 71.4% approval.
The CEO-to-median-worker pay ratio at Pfizer is 561:1. The median worker at Pfizer earns $30K per year, while CEO Albert Bourla earns $17.0M in total compensation.
Pfizer employs approximately 88,000 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $58.5B in annual revenue.